![](/img/cover-not-exists.png)
Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP)
Massachi, Samira, Epstein, Josh, Hurd, Julie, Bonkovsky, Herbert L.Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2020.1835306
Date:
October, 2020
File:
PDF, 1.41 MB
2020